Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-16

FDA Approved: ASMANEX — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for ASMANEX (mometasone furoate) submitted by Organon LLC. The supplement pertains to the inhaled corticosteroid product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASMANEX (MOMETASONE FUROATE)

Snippet

SUPPL AP for ASMANEX (MOMETASONE FUROATE)